SEC 13F Intelligence

Managers / Q3 2024 · view latest →

HARBOURVEST PARTNERS LLC

CIK 0001201001 · ONE LINCOLN STREET, SUITE 1700, BOSTON, MA, 02111 · 617-348-3707

Reported Value
$192M
Q3 2024
Positions
34
Filings on Record
32
2019–present window
Filed
Nov 14, 2024
original filing

Summary

Harbourvest Partners LLC reported $192M in U.S.-listed holdings across 34 positions for Q3 2024.

The portfolio is heavily concentrated: TOST alone accounts for 33.6% of reported value.

Compared with Q2 2024, the fund opened 0 new positions and exited 6.

Portfolio Metrics

Turnover
+5.3%
vs prior filed quarter
Top-10 Concentration
+90.8%
share of reported value
Largest Position
+33.6%
Toast

Methodology: turnover is min(value bought, value sold) ÷ average reported value across the two quarters — value-based, so market moves inflate it slightly versus a share-based measure. Concentration and largest position are shares of the filing’s total reported value, options excluded. New/exited counts compare against the prior filed quarter. All figures derive solely from the fund’s 13F filings.

Reported Value by Quarter

13F Reported Value
Q4 ’18: $211MQ4 ’18Q1 ’19: $283MQ2 ’19: $262MQ3 ’19: $240MQ4 ’19: $243MQ4 ’19Q1 ’20: $207MQ2 ’20: $232MQ3 ’20: $270MQ4 ’20: $256MQ4 ’20Q1 ’21: $746MQ2 ’21: $1.0BQ3 ’21: $1.1BQ4 ’21: $782MQ4 ’21Q1 ’22: $490MQ2 ’22: $305MQ3 ’22: $306MQ4 ’22: $299MQ4 ’22Q1 ’23: $297MQ2 ’23: $352MQ3 ’23: $295MQ4 ’23: $299MQ4 ’23Q1 ’24: $219MQ2 ’24: $188MQ3 ’24: $192MQ4 ’24: $203MQ4 ’24Q1 ’25: $154MQ2 ’25: $91MQ3 ’25: $205MQ4 ’25: $174MQ4 ’25Q1 ’26: $101Mfilingsflow.com

Portfolio Composition

By security type
Common Stock: 91.7%ADR: 6.0%Other: 2.4%
  • Common Stock · 91.7% · $176M
  • ADR · 6.0% · $11M
  • Other · 2.4% · $5M

Quarter-over-Quarter Changes full breakdown →

vs Q2 2024 (amended baseline)

IssuerMoveShare ΔShares nowValue ΔValue now
ACVAACV Auctions, Inc.SOLD OUT−108.1K0−$2M$0
IASIntegral Ad Science, Inc.SOLD OUT−91.8K0−$892,092$0
COURCoursera, Inc.SOLD OUT−106.1K0−$759,762$0
EB4Eventbrite, Inc.SOLD OUT−102.2K0−$494,474$0
Aligos Therapeutics, Inc.SOLD OUT−18.8K0−$6,574$0
Astra Space, Inc.SOLD OUT−12.4K0−$6,263$0
QSQuantumScape CorporationTRIMMED−27.5K29.0K−$111,507$166,468
TOSTToast, Inc.HELD+02.28M+$6M$65M

Value changes conflate price moves with buying and selling — share changes are the real signal. Share counts are not split-adjusted.

Holdings — Q3 2024

34 positions
Export to Excel
#IssuerClass% PortfolioValue ↓Shares
1TOSTToast, Inc.history →Common CLA33.60%$65M2.28M
2WWayfair Inc.history →Common CLA31.02%$60M1.06M
3HCP2EURHashiCorp, Inc.history →Common CLA11.83%$23M671.9K
4YMMFull Truck Alliance Co. Ltd.history →Sponsored ADS4.49%$9M957.6K
5LCEURLendingClub Corp.history →Common NEW3.05%$6M513.4K
6Omega Therapeutics, Inc.Common2.23%$4M3.51M
7HSAIHesai Grouphistory →Sponsored ADS1.48%$3M606.1K
8DOCSDoximity, Inc.history →Common CLA1.13%$2M49.8K
9RLAYRelay Therapeutics, Inc.history →Common1.09%$2M296.4K
10DOCNDigitalOcean, Inc.Common0.93%$2M44.2K
11BEBloom Energy CorporationCommon CLA0.89%$2M162.2K
12HNSTHonest Company Inc.Common0.88%$2M475.6K
13OLOGBXOlo, Inc.Common CLA0.88%$2M341.8K
14Inari MedicalCommon0.83%$2M38.5K
15PGNYProgyny, Inc.Common0.78%$2M89.7K
16ZUOUSDZuora, Inc.Common CLA0.73%$1M163.9K
17AMPLAmplitude Inc.Common CLA0.71%$1M153.0K
18IBRXImmunityBio, Inc.Common0.65%$1M335.7K
19SONDQSonder Holdings, Inc.CL A NEW0.55%$1M225.1K
20AFRMAffirm, Inc.Common CLA0.49%$947,43223.2K
21DIBS1stdibs.com, Inc.Common0.46%$879,777199.5K
22UUnity SoftwareCommon0.40%$773,46834.2K
23PLRXPliant Therapeutics, Inc.Common0.29%$554,15549.4K
24GTMZoomInfo Technologies IncCommon0.21%$399,31238.7K
25NeueHealth, Inc.Common NEW0.14%$275,19852.7K
26QSQuantumScape CorporationCommon CLA0.09%$166,46829.0K
27OPENOpendoor Technologies Inc.Common0.05%$93,41446.7K
28IPSCCentury Therapeutics, Inc.Common0.03%$49,62129.0K
29MCRB1EURSeres Therapeutics, Inc.Common0.02%$46,70249.4K
30RPTXRepare Therapeutics, Inc.Common0.02%$42,22912.3K
31PACBPacific Biosciences of California, Inc.Common0.02%$39,92323.5K
32Rallybio Holdings, LLCCommon0.01%$25,59621.9K
33PMVPPMV PharmaceuticalsCommon0.01%$17,18411.5K
34NXTCEURNextCure, Inc.Common0.01%$13,76010.0K

Filing History

QuarterReported ValuePositionsFiledTypeLinks
Q1 2026$101M5May 15, 202613F-HRchanges · EDGAR ↗
Q4 2025$174M7Feb 17, 202613F-HRchanges · EDGAR ↗
Q3 2025$205M9Nov 14, 202513F-HRchanges · EDGAR ↗
Q2 2025$91M15Aug 14, 202513F-HRchanges · EDGAR ↗
Q1 2025$154M16May 15, 202513F-HRchanges · EDGAR ↗
Q4 2024$203M22Feb 14, 202513F-HRchanges · EDGAR ↗
Q3 2024$192M34Nov 14, 202413F-HRchanges · EDGAR ↗
Q2 2024$188M40Aug 14, 202413F-HRchanges · EDGAR ↗
Q1 2024$219M48May 15, 202413F-HRchanges · EDGAR ↗
Q4 2023$299M53Feb 14, 202413F-HRchanges · EDGAR ↗
Q3 2023$295M58Nov 14, 202313F-HRchanges · EDGAR ↗
Q2 2023$352M60Aug 14, 202313F-HRchanges · EDGAR ↗
Q1 2023$297M63May 15, 202313F-HRchanges · EDGAR ↗
Q4 2022$299M65Feb 14, 202313F-HRchanges · EDGAR ↗
Q3 2022$306M67Nov 14, 202213F-HRchanges · EDGAR ↗
Q2 2022$305M62Aug 15, 202213F-HRchanges · EDGAR ↗
Q1 2022$490M66May 26, 2022RESTATEMENTchanges · EDGAR ↗
Q4 2021$782M67Feb 14, 202213F-HRchanges · EDGAR ↗
Q3 2021$1.1B56Nov 15, 202113F-HRchanges · EDGAR ↗
Q2 2021$1.0B51Aug 13, 202113F-HRchanges · EDGAR ↗
Q1 2021$746M44May 17, 202113F-HRchanges · EDGAR ↗
Q4 2020$256M26Feb 16, 202113F-HRchanges · EDGAR ↗
Q3 2020$270M36Nov 12, 202013F-HRchanges · EDGAR ↗
Q2 2020$232M28Aug 13, 202013F-HRchanges · EDGAR ↗
Q1 2020$207M36May 14, 202013F-HRchanges · EDGAR ↗
Q4 2019$243M35Feb 13, 202013F-HRchanges · EDGAR ↗
Q3 2019$240M33Nov 13, 201913F-HRchanges · EDGAR ↗
Q2 2019$262M32Aug 13, 201913F-HRchanges · EDGAR ↗
Q1 2019$283M33May 13, 201913F-HRchanges · EDGAR ↗
Q4 2018$211M32Feb 14, 201913F-HRchanges · EDGAR ↗

13F filings are due up to 45 days after quarter end, so holdings shown here lag the fund’s current book. Source: original SEC filing on EDGAR ↗.